IP Library Granted Patent US 9,010,325
Granted Patent B2
US 9,010,325 · App. 12/516,404 · Granted Apr 21, 2015

Nasal delivery devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,010,325
App. No.
12/516,404
Granted
Apr 21, 2015
Kind
B2
Abstract

A nasal delivery device for and method of delivering particulate substance to the nasal airway of a subject, the delivery device comprising: a body assembly ( 3 ) including a mouthpiece unit ( 9 ) which includes a mouthpiece through which the subject in use exhales, and a substance-supply unit which is fluidly connected to the mouthpiece unit and actuatable to provide particulate substance for delivery to the nasal airway of the subject; wherein the body assembly is configured to receive a replaceable nosepiece unit ( 5 ) which includes a nosepiece and contains a container containing particulate substance.

Claims (23)

1. A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising:

a body assembly including a mouthpiece unit which includes a mouthpiece through which the subject in use exhales, a substance-supply unit which is fluidly connected to the mouthpiece unit and configured to receive a replaceable nosepiece unit which includes a nosepiece and contains a container containing particulate substance, and an actuation mechanism which is manually actuatable by the subject to open the container;

wherein the substance-supply unit is actuatable to provide particulate substance for delivery to the nasal airway of the subject, and includes an interlock mechanism which adopts a first, locking configuration when a nosepiece unit is not fitted to the body assembly, in which the actuation mechanism is locked, and a second, released configuration when a nosepiece unit is fitted to the body assembly, in which the actuation mechanism is actuatable.

2. The delivery device of claim 1 , further comprising:

a replaceable nosepiece unit which includes a nosepiece for fitting to a nostril of a subject, and a container chamber which contains a container containing particulate substance.

3. A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising:

a body assembly including a mouthpiece unit which includes a mouthpiece through which the subject in use exhales, a substance-supply unit which is fluidly connected to the mouthpiece unit and configured to receive a replaceable nosepiece unit which includes a nosepiece and contains a container containing particulate substance, and an actuation mechanism which is manually actuatable by the subject to open the container;

wherein the substance-supply unit is actuatable to provide particulate substance for delivery to the nasal airway of the subject, and includes an interlock mechanism which adopts a first, locking configuration when a nosepiece unit is not fitted to the body assembly, in which the actuation mechanism is not actuatable, and a second, released configuration when a nosepiece unit is fitted to the body assembly, in which the actuation mechanism is actuatable;

wherein the interlock mechanism comprises an interlock member which is movably disposed between locking and released positions and normally biased to the locking position.

4. A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising:

a body assembly including a mouthpiece unit which includes a mouthpiece through which the subject in use exhales, and a substance-supply unit which is fluidly connected to the mouthpiece unit and configured to receive a replaceable nosepiece unit which includes a nosepiece and contains a container containing particulate substance;

wherein the substance-supply unit is actuatable to provide particulate substance for delivery to the nasal airway of the subject, and includes an interlock mechanism which adopts a first, locking configuration when a nosepiece unit is not fitted to the body assembly, in which the actuation mechanism is not actuatable, and a second, released configuration when a nosepiece unit is fitted to the body assembly, in which the actuation mechanism is actuatable, and a valve unit which is operable between a first, closed configuration in which a fluid communication path with the mouthpiece is closed, and a second, open configuration in which the fluid communication path is open, and the interlock mechanism is configured to lock the valve unit in the closed configuration when the interlock mechanism is in the locking configuration and allow operation of the valve unit when the interlock mechanism is in the released configuration.

5. The delivery device of claim 4 , further comprising:

a replaceable nosepiece unit which includes a nosepiece for fitting to a nostril of a subject, and a container chamber which contains a container containing particulate substance.

6. The delivery device of claim 4 , wherein the valve unit includes a locking element which is engaged by the interlock mechanism when the interlock mechanism is in the locking configuration to prevent operation of the valve unit.

7. A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising:

a body assembly including a mouthpiece unit which includes a mouthpiece through which the subject in use exhales, and a substance-supply unit which is fluidly connected to the mouthpiece unit and configured to receive a replaceable nosepiece unit which includes a nosepiece and contains a container containing particulate substance;

wherein the substance-supply unit is actuatable to provide particulate substance for delivery to the nasal airway of the subject, and includes an interlock mechanism which adopts a first, locking configuration when a nosepiece unit is not fitted to the body assembly, in which the actuation mechanism is locked in a locked configuration to prevent operation of the actuation mechanism, and a second, released configuration when a nosepiece unit is fitted to the body assembly, in which the actuation mechanism is actuatable.

8. The delivery device of claim 7 , wherein the nosepiece unit includes a release member for releasing the actuation mechanism from the locked configuration on fitting the nosepiece unit to the body assembly.

9. The delivery device of claim 8 , wherein the actuation mechanism includes an actuation member which is latched in a locked position in the locked configuration of the actuation mechanism, and the release member of the nosepiece unit is operative to release the latched actuation member on fitting the nosepiece unit to the body assembly.

10. The delivery device of claim 8 , wherein the nosepiece unit is fitted to the body assembly in one, fitting sense and removed from the body assembly in the opposite, removal sense, and the release member includes a support element, an engagement element for engaging the actuation mechanism and a frangible connection element which connects the support element to the engagement element, wherein the engagement element presents a substantially rigid structure when the nosepiece unit is fitted in a first instance to the body assembly and is operative to release the actuation mechanism from the locked configuration, and is deformed on removing the nosepiece unit from the body assembly.

11. The delivery device of claim 7 , further comprising:

a replaceable nosepiece unit which includes a nosepiece for fitting to a nostril of a subject, and a container chamber which contains a container containing particulate substance.

Assignments (12)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 71337/0132 Recorded Mar 17, 2026
From: OAKTREE FUND ADMINISTRATION, LLC
To: OPTINOSE, INC.
Reel/Frame 075101/0804 →
PATENT SECURITY AGREEMENT Recorded Mar 16, 2026
From: OPTINOSE, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 075111/0018 →
SECURITY INTEREST Recorded May 22, 2025
From: OPTINOSE, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071337/0132 →
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 8, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069848/0027 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE; SHELDRAKE, COLIN DAVID; SMITH, SIMON; STRIEBIG, RACHEL; PIDGEON, ANDY; ST. QUINTIN, TOM
To: OPTINOSE AS
Reel/Frame 042704/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: DJUPESLAND, PER GISLE; SHELDRAKE, COLIN DAVID; SMITH, SIMON; STRIEBIG, RACHEL; PIDGEON, ANDY; ST. QUINTIN, TOM
To: OPTINOSE AS
Reel/Frame 024428/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2009
From: DJUPESLAND, PER GISLE; SHELDRAKE, COLIN DAVID
To: OPTINOSE AS
Reel/Frame 023062/0763 →